FDA Inspection 714277 — CorePharma, LLC

CorePharma, LLC — FEI 3002535019

The FDA completed an inspection of CorePharma, LLC on Feb 25, 2011 in Middlesex, NJ. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 6 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Official Action Indicated (OAI)
End Date
Feb 25, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Middlesex, NJ (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
144821 CFR 211.111Establishment of time limitations
155021 CFR 211.125(f)Procedures Written and Followed
202721 CFR 211.192Investigations of discrepancies, failures
360221 CFR 211.160(a)Deviations from laboratory control requirements

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.